GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CSL Ltd (MEX:CSL N) » Definitions » Future 3-5Y Total Revenue Growth Rate

CSL (MEX:CSL N) Future 3-5Y Total Revenue Growth Rate : 7.15 (As of Jun. 29, 2025)


View and export this data going back to 2019. Start your Free Trial

What is CSL Future 3-5Y Total Revenue Growth Rate?

Future 3-5Y Total Revenue Growth Rate is the average growth rate of total revenue estimates over a 3-year to 5-year period.

As of today, CSL's Future 3-5Y Total Revenue Growth Rate is 7.15.


Competitive Comparison of CSL's Future 3-5Y Total Revenue Growth Rate

For the Biotechnology subindustry, CSL's Future 3-5Y Total Revenue Growth Rate, along with its competitors' market caps and Future 3-5Y Total Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CSL's Future 3-5Y Total Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CSL's Future 3-5Y Total Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where CSL's Future 3-5Y Total Revenue Growth Rate falls into.


;
;

CSL  (MEX:CSL N) Future 3-5Y Total Revenue Growth Rate Explanation

Future 3-5Y Total Revenue Growth Rate is the growth rate of total revenue estimates over a 3-year to 5-year period. This data is provided directly by our trusted data vendors Refinitiv or Morningstar.

In situations where both vendors do not directly provide the growth rate data, we use the most recent annual revenue for the current year and estimated future revenue figures provided by the vendor to calculate the growth rate. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average total revenue estimates growth rate.


CSL Future 3-5Y Total Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of CSL's Future 3-5Y Total Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


CSL Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CSL Ltd (MEX:CSL N) » Definitions » Future 3-5Y Total Revenue Growth Rate
Address
655 Elizabeth Street, Melbourne, VIC, AUS, 3000
CSL is one of the largest global biotech companies and has two main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders and neurological indications. Seqirus is now the world's second largest influenza vaccination business and was acquired in fiscal 2015. CSL has a strong R&D track record, and the product portfolio and pipeline include nonplasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.

CSL Headlines

No Headlines